@groupbenefitsmg Excellent point!

@GroupBenefitsMG Excellent point!

RT @GroupBenefitsMG: @KipPiper @ShimCode Good to r…

RT @GroupBenefitsMG: @KipPiper @ShimCode Good to recognize limitations (incl often overlooked network), but believe some ins exponentially > none, esp outside ER

RT @GroupBenefitsMG: @KipPiper Yes, and regional r…

RT @GroupBenefitsMG: @KipPiper Yes, and regional robustness of networks crucial to assessment. Not an overriding value but of value that should be measurable 1/3

RT @GroupBenefitsMG: @brycewatch @cjrylands Much t…

RT @GroupBenefitsMG: @brycewatch @cjrylands Much tbd but still pressure on plan sponsors: if 2014 ESI not affordable, hard to lure those subsidized back for 2015

RT @GroupBenefitsMG: Variance and opacity in gener…

RT @GroupBenefitsMG: Variance and opacity in generic Rx pricing via @latimesbiz lat.ms/108hMV3

@GroupBenefitsMG Thanks, Dave! Very kind.

@GroupBenefitsMG Thanks, Dave! Very kind.

@GroupBenefitsMG Thank you, kind sir.

@GroupBenefitsMG Thank you, kind sir.

RT @GroupBenefitsMG: More excellent information fo…

RT @GroupBenefitsMG: More excellent information for improving employee health via @WorldatWork and @heroehm ow.ly/hVzwS